EOM Pharmaceutical Holdings, Inc. (OTCMKTS:IMUC – Get Free Report)’s stock price rose 4% on Thursday . The stock traded as high as $0.25 and last traded at $0.2078. Approximately 114,008 shares were traded during mid-day trading, an increase of 906% from the average daily volume of 11,330 shares. The stock had previously closed at $0.1998.
EOM Pharmaceutical Stock Up 2.3%
The company’s fifty day moving average is $0.13 and its two-hundred day moving average is $0.15.
About EOM Pharmaceutical
EOM Pharmaceutical, trading under the ticker OTCMKTS:IMUC, is a clinical-stage biotechnology company focused on the development of cell-based immunotherapies for the treatment of solid tumors. The company leverages dendritic cell technology to create personalized therapeutic vaccines designed to activate a patient’s immune system against tumor-specific antigens. By harnessing key insights into antigen presentation and T-cell activation, EOM Pharmaceutical aims to improve survival outcomes for patients with cancers that currently have limited treatment options.
The company’s lead programs are directed at glioblastoma multiforme and other aggressive tumor types, where standard therapies often fall short.
Featured Stories
- Five stocks we like better than EOM Pharmaceutical
- Samsara Just Answered The AI Question—Is Wall Street Ready To Listen?
- IREN’s 800MW Bet Flips the AI Power Switch
- CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip?
- Tesla’s EV Rebound Leaves Rivian and Lucid Facing a Tougher Investor Test
Receive News & Ratings for EOM Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EOM Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
